Diffuse pleural mesothelioma (DPM) is a highly aggressive malignant neoplasm arising from
the mesothelial cells lining the pleural surfaces. While DPM is a well-recognized disease …

Mesothelioma is a type of late‐onset cancer that develops in cells covering the outer surface
of organs. Although it can affect the peritoneum, heart, or testicles, it mainly targets the lining …

Abstract Background Malignant Pleural Mesothelioma (MPM) is a dreadful disease escaping
the classical genetic model of cancer evolution and characterized by wide heterogeneity …

Background Malignant mesothelioma (MM) is a rare tumor with a dismal prognosis. The low
efficacy of current treatment options highlights the urge to identify more effective therapies …

We assessed the murine Stimulator of Interferon Genes (STING) agonist, DMXAA, for anti-
mesothelioma potential using the AE17-sOVA model that expresses ovalbumin (OVA) as a …

The pathetic malignant mesothelioma (MM) is a extremely uncommon and confrontational
tumor that evolves in the mesothelium layer of the pleural cavities (inner lining-visceral …

Simple Summary Malignant pleural mesothelioma (MPM) is a disease of the pleura related
to asbestos exposure. Despite the advancements in new therapeutic frontiers, it has a …

Objectives Malignant pleural mesothelioma (MPM) is an aggressive disease with grim
prognosis due to lack of effective treatment options. Disease prediction in association with …

Background Diffuse pleural mesothelioma (DPM) is an aggressive therapy-resistant cancer
with unique molecular features. Numerous agents have been tested, but clinically effective …

Malignant pleural mesothelioma (MPM) is a rare cancer usually caused by asbestos
exposure and associated with a very poor prognosis. After more than a decade without new …